Acute Appendicitis and Microbiota - Etiology of Appendicitis and Antibiotic Therapy Effects

NAEnrolling by invitationINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

April 4, 2017

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2025

Conditions
Acute Appendicitis
Interventions
DRUG

Ertapenem followed by levofloxacin and metronidazole

Ertapenem 1 g i.v. daily for either 2 days (MAPPAC + APPAC II patients) or 3 days (MAPPAC + APPAC III) followed by p.o. levofloxacin 500 mg x 1 + metronidazole 500 mg x 3 for either 5 days (APPAC II + MAPPAC) or 4 days (APPAC III + MAPPAC)

DRUG

Moxifloxacin

Moxifloxacin 400 mg once a day for seven days (APPAC II + MAPPAC)

PROCEDURE

Appendectomy

Primarily laparoscopic appendectomy for either complicated acute appendicitis or uncomplicated acute appendicitis (refusing to participate in APPAC II or III trials or recurrent acute appendicitis).

OTHER

Placebo

Placebo i.v. once a day for three days (APPAC III + MAPPAC) followed by placebo capsules three times a day for four days.

Trial Locations (1)

Unknown

Turku University Hospital, Turku

All Listed Sponsors
collaborator

Tampere University Hospital

OTHER

collaborator

Oulu University Hospital

OTHER

collaborator

Kuopio University Hospital

OTHER

collaborator

Helsinki University Central Hospital

OTHER

collaborator

Jyväskylä Central Hospital

OTHER

lead

Turku University Hospital

OTHER_GOV